Rafferty Asset Management
AMAG

Rafferty Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Rafferty Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-76,693
Closed -$933K – 881
2019
Q4 		$933K Sell
76,693
-52,015
-40% -$568K 0.01% 569
2019
Q3 		$1.49M Buy
128,708
+1,200
+0.9% +$12.6K 0.02% 462
2019
Q2 		$1.27M Buy
127,508
+4,645
+4% +$50.1K 0.02% 511
2019
Q1 		$1.58M Buy
+122,863
New +$1.83M 0.03% 459

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Rafferty Asset Management's AMAG Position: Q1 2020 in Review

Rafferty Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2020, closing a stake of 76,693 shares — an estimated $933K sold.

Rafferty Asset Management first reported a position in AMAG in Q1 2019 and held it in 4 quarters. The position peaked at $1.58M in Q1 2019. 119 funds tracked by Wall St. Rank hold AMAG as of Q1 2020.

  • Rafferty Asset Management reported no remaining AMAG Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Rafferty Asset Management sold 76,693 AMAG Pharmaceuticals shares in Q1 2020, an estimated $933K.
  • Rafferty Asset Management first reported a position in AMAG Pharmaceuticals in Q1 2019 and held it in 4 quarters.
  • Rafferty Asset Management's AMAG Pharmaceuticals position peaked at $1.58M in Q1 2019.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2020.

Based on Rafferty Asset Management's 13F filing for Q1 2020, filed 15 May 2020.